A Randomized, Double-Blind, Placebo-Controlled Study of Odanacatib (MK-822) In The Treatment of Postmenopausal Women With Low BMD: 18-Month Results
Cosman, Felicia, McClung, Michael, Rybak-Feiglin, Andrea, daSilva, Carolyn, Santora, Arthur, Ince, AveryVolume:
11
Language:
english
Journal:
Journal of Clinical Densitometry
DOI:
10.1016/j.jocd.2008.05.074
Date:
July, 2008
File:
PDF, 145 KB
english, 2008